Skip to content

Invest1 publisher3 min readPublished

Anthropic advisers say slower model pace would not necessarily hurt finances

Anthropic's annualized run rate crossed $100 billion in the same week its chief executive asked the industry to slow capability development. People familiar with the listing say a slower release schedule would not move the numbers.

The Investor · Invest desk

Illustration accompanying Anthropic advisers say slower model pace would not necessarily hurt finances

What happened

  • Anthropic moved its planned listing from October to November so third-quarter results can be presented to investors before shares begin trading.
  • Dario Amodei published a 3,900-word essay, "We Must Pace the Frontier", asking AI companies to slow capability improvement until safety verification catches up.
  • Jacob Coxon, a pretraining researcher who worked at both OpenAI and Anthropic, resigned on September 8 and forfeited unvested equity, in a post that drew more than 170 million views.

Compiled by The InvestorSomething wrong?How this is made

Why it matters

  • constraint If the advisers' account holds, the pacing pledge binds nothing that generates revenue this year, so the only thing it constrains is a model pipeline buyers are not paying for yet.
  • cost The SpaceX compute commitment runs to $15 billion a year, or 15 percent of a $100 billion run rate, and slowing model releases does not reduce a fixed monthly bill.
  • exposure Anthropic's own alignment science lead has put his assessment of the company's superintelligence readiness on the public record before any prospectus exists. Risk-factor drafting and later disclosure arguments both start from that public record.
  • decision The extra month means buyers see one quarter of results with the pacing commitment already public, so they learn whether growth decelerated before they commit money.

The people making the claim that a slower release pace is free are the ones advising the sale. Advisers believe even a slower pace of new model releases "would not necessarily have a major effect on Anthropic's financial prospects," people familiar with the IPO planning told the Wall Street Journal. Their reasoning: the revenue behind the run rate comes from Claude models already deployed [7][8]. Set that against the sequence: roughly $9 billion at the end of 2025 [17], about $14 billion in February and past $30 billion by April [18], past $47 billion in May [19], $65 billion in July on Bloomberg's confirmation [20], past $100 billion on Friday [1]. More than tenfold in a calendar year by the Times's count, and about eleven times on the two endpoints [21][1]. Thirty-five billion of that arrived in the last two months, about $17.5 billion of added annualized run rate a month [6]. The account does not link those steps to specific model releases.

The May round is the cleanest price anyone has actually paid: $65 billion in, at $965 billion post-money, against a run rate that had just passed $47 billion [19]. Call it 20 times [2]. On Friday's figure the same private mark is 9.7 times, and the money that went in bought about 6.7 percent of the company [2][3]. Investors now put the annualized rate at between $100 billion and $120 billion [22]. The floor of that forecast is where the company already is [5].

Pacing would cost something, though not in the revenue line. Amodei asked for third-party evaluators embedded inside frontier labs with employee-level access, voluntary coordination on safety standards among AI companies in democratic countries, and a push for coordination with authoritarian governments too [4]. The first of those puts outside staff inside the perimeter where a listed company keeps material non-public information. Elon Musk, whose SpaceX sells Anthropic compute capacity, posted "Dario is right" [16].

"I actually think that, given everything happening with safety, right now would be an ill-advised moment to go public, and we don't feel pressure on that," Altman told Fortune [14]. He also wrote on X that "I agree with Dario that we need to pace the frontier" [15].

In my view the essay costs Anthropic nothing in the quarter it is about to put in front of buyers. The postponement is the evidence: a company worried a pacing pledge would dent bookings does not volunteer another quarter of bookings before pricing. Two ways to be wrong. If the third quarter shows growth off that $17.5 billion a month, then $100 billion annualized was one moment on a curve and release cadence does matter [6]. The other is disclosure. Evan Hubinger, who leads alignment science at Anthropic, wrote that the company "does not yet have a plan to solve alignment for superintelligence and are not clearly on track to," and he put his own estimate of human extinction within the decade above 10 percent [12][11].

What to watch

  • The third-quarter statement Anthropic promised buyers before trading, and whether growth held near $17.5 billion of added run rate a month.
  • Whether any frontier lab accepts embedded third-party evaluators with employee-level access, and on what contract terms.
  • Whether Anthropic's prospectus risk factors carry alignment language as blunt as its own science lead's posts.
Loading claim ledger
Loading source directory links
Loading share composer
Loading topic controls
Loading related stories